Despite the fact that TRPV1 receptors are widely expressed in brain structures such as the hippocampus, its functions remain largely unknown. In the present study, we have investigated the possible modulatory role of the hippocampal endovanilloid system upon memory consolidation of two different behavioral tasks in rats. Post-training infusion of the TRPV1 antagonist capsazepine disrupted memory consolidation with a strong training protocol, but not with a weak one in the contextual fear conditioning or in the stepdown inhibitory avoidance task. These results provide evidence that the modulation of the hippocampal memory consolidation through TRPV1 receptors takes place only in presence of a strong emotional experience, suggesting that a certain aversiveness level is required in order to recruit endovanilloids to exert this function. A possible synergic role of hippocampal endovanilloid and endocannabinoid system on memory consolidation is discussed.
Introduction
TRPV1 (transient receptor potential vanilloid type 1), originally called VR1, is a calcium-permeable cation channel (Szallasi & Blumberg, 1999) . In the peripheral nervous system, this receptor can be modulated by high temperatures, extracellular protons and chemical ligands, such as capsaicin and the endocannabinoid anandamide (Al-Hayani, Wease, Ross, Perwtee, & Davies, 2001; Smart et al., 2000; Tominaga et al., 1998) . Although TRPV1 channels are highly expressed in primary sensory afferent neurons, they are also present in brain areas, including the hippocampus (Mezey et al., 2000; Tóth et al., 2005) . In this brain structure, TRPV1 receptors are mainly found in the postsynaptic dendrites spines and cell somata (Cristino et al., 2006; Tóth et al., 2005) . In contrast, a recent study has reported a restricted expression of TRPV1 receptors in the brain (Cavanaugh et al., 2011) . Nonetheless, electrophysiological studies strongly support the expression and functional role of the TRPV1 receptors in the brain, such as its involvement in long term potentiation (LTP) (Bennion et al., 2011; Marsch et al., 2007) and long term depression (LTD) (Chávez, Chiu, & Castillo, 2010) in the hippocampus.
Three classes of endovanilloids activate TRPV1 directly: anandamide, N-acyldopamines (e.g., N-arachidonyl-dopamine or NADA) and hydroperoxyeicosatetraenoic acids (HPETEs) (Huang et al., 2002; Ross, 2003; Zygmunt et al., 1999) . Both anandamide and NADA are also members of the endocannabinoid family, since they bind to CB1 receptors as well. In fact, TRPV1 and CB1 are colocalized in several brain structures, including the hippocampus (Cristino et al., 2006) . However, whereas TRPV1 receptors are found in the postsynaptic membrane (Tóth et al., 2005) , CB1 receptors are expressed mostly presynaptically in axon terminals (Wilson & Nicoll, 2002) . Despite extensive work showing the involvement of CB1 receptors in brain functions such as memory (Abush & Akirav, 2010; de Oliveira Alvares et al., 2005) , TRPV1 roles in the CNS remain largely unknown. Recent report has shown an axiolytic effect of TRPV1 antagonist infused into the medial prefrontal cortex, suggesting that the TRPV1 receptors may participate on the modulation of the anxiety behavior (Aguiar, Terzian, Guimarães, & Moreira, 2009; see Moreira, Aguiar, Terzian, Guimarães, & Wotjak, 2011 for a wider review).
Two recent studies, either using TRPV1 knock-out mice or pharmacological tools, have found some behavioral and synaptic plasticity effects of endovanilloids acting upon TRPV1 receptors. Marsch and colleagues have reported that TRPV1-deficient mice show less anxiety-like behavior in the elevated plus maze and dark-light transition task than the wild-type littermate. They also display a poor contextual fear memory with strong (but not with moderate) training stimulus, and a weaker LTP induction (Marsch et al., 2007 slices and prevented spatial memory retrieval deficit caused by acute stress, while the selective antagonist capsazepine was able to suppress long-term depression (Li et al., 2008) .
Interestingly, in both studies, the endovanilloid function on memory appears to be important when some level of stress is present. However, in the first study it was not possible to conclude if the memory effect acted upon acquisition or retrieval. Moreover, since the TRPV1 receptors expression are constitutively arrested in these genetically modified mice, a compensatory process and/ or differences in genetic background may have contributed to the phenotype observed (Marsch et al., 2007) .
In the present study we aim to perform a deeper evaluation of the modulatory role of the dorsal hippocampus endovanilloid system -using TRPV1 agonists or antagonists -on memory consolidation. Drugs were infused immediately after training in two aversive tasks with different stress/aversiveness levels.
Material and methods

Animals
In the experiments, 248 male Wistar rats (age 3-4 months, weight 270-320 g) from our breeding colony were used. The animals were housed in plastic home-cages, 4-5 per cage, under a 12-h light/dark cycle and at constant temperature (24 ± 1°C), with water and food available ad libitum. Behavioral tests were performed at daytime only.
Stereotaxic surgery and cannulae placement
Rats were deeply anesthetized by an i.p. injection of ketamine/ xylazine (75 and 10 mg/kg, respectively) and bilaterally implanted with 27-gauge guide cannulae aimed at AP _4.2 mm (from bregma), LL ±3.0 mm, DV 1.8 mm, positioned just 1.0 mm above the region of the dorsal hippocampus (according to Paxinos and Watson (1998) ). Before the behavioral tests, animals were allowed a recovery period of 5-7 days.
Drugs and administration
Capsaicin and capsazepine (Tocris) were dissolved in a vehicle solution (8% DMSO in 0.1 M of a phosphate-buffered saline -PBS solution). At the time of infusion, 30-gauge infusion cannulae was fitted into the guide cannulae, its tip protruding 1.0 mm from the cannulae end, and aimed at the pyramidal cell layer of CA1 in the dorsal hippocampus. A volume of 0.5 ll of capsaicin (0.1, 1 and 10 lM), capsazepine (2, 10 and 20 lM), or vehicle (control group) was mechanically and slowly infused (during 90 s) immediately after training.
2.4.
Step-down inhibitory avoidance (IA)
The step-down inhibitory avoidance task was carried out in an automatically operated, brightly illuminated box (Albarsch; 15 W lamp), in which the left extreme of the grid (42.0 Â 25.0 cm grid of parallel 0.1 cm caliber bronze bars spaced 1.0 cm apart) was covered with a 7.0 cm wide, 5.0 cm high formica-covered platform. The Illumination inside the room was $400-800 lux. Animals were placed on the platform and the latency to step-down, placing their four paws on the grid, was recorded. In the training session, immediately after stepping down, a 0.7 or 0.5 mA, 3.0 s scrambled footshock was delivered. In the test session, no foot-shock was given, and a ceiling of 180 s was imposed on the step-down latency.
Contextual fear conditioning (CFC)
The conditioning chamber consisted of an illuminated Plexiglas box (25.0 Â 25.0 cm grid of parallel 0.1-cm caliber stainless steel bars spaced 1.0 cm apart). The Illumination inside the room was $400-800 lux. In the conditioning session (training), rats were placed in the chamber for 3 min for habituation, and then received two 2-s foot-shocks, either of 0.3 or 0.7 mA, separated by a 30-s interval. Before returning to their home cages, animals were kept in the conditioning environment for an additional minute. Twenty-four hours later, all animals were tested during 5 min in the same context.
Elevated plus maze
The elevated plus maze (EPM) test was conducted using a standard plus maze apparatus kept 80 cm above the floor, consisting of four arms arranged in the shape of a plus sign (arms measured 50 Â 10 cm). The four arms were joined at the center by a 10 cm square platform. Two of the arms, opposite to each other, were surrounded by a 1 cm high Plexiglas ledge (open arms), and two other arms (closed arms) were enclosed by a 40-cm-high wall. The Illumination inside the room was $50 lux. The animal was placed in the center of the plus maze, facing one of the open arms, and remained in the apparatus for 5 min. The number of entries and the time spent in the open arm were analyzed.
Statistical analysis
Non-parametric statistics were necessary to analyze the stepdown latencies of IA task since these data were not normally distributed (P < 0.05, Kolmogorov-Smirnov test with Lilliefors' correction). Independent groups were analyzed by Kruskal-Wallis test. Wilcoxon signed ranks test were used to compare training vs. test. In CFC, data was analyzed by One-way ANOVA, followed by Tukey all-pairwise multiple comparison post-hoc test or independent t test. Statistical analysis was limited to the 248 out of 263 animals with correct cannulae placements (see Fig. 7 ). Statistical significance was accepted if P < 0.05.
Ethical aspects
All experimental procedures in living animals were performed in strict accordance to the recommendations of the Brazilian Society for Neurosciences (SBNeC) and Brazilian Law on the use of animals (Federal Law Nr. 11.794/2008 ).
Results
Effect of TRPV1 agonist and antagonist in the inhibitory avoidance task
In the first sets of experiments, we investigated the role of the vanilloid system in memory consolidation using the inhibitory avoidance task. Rats received a bilateral intra-hippocampal infusion of 0.1, 1 or 10 lM of the TRPV1 agonist capsaicin, immediately after the training session, in which 0.5 mA foot-shock was applied. There was no difference on step-down latencies among the groups, neither in the training (P = 0.791) nor in the test sessions (P = 0.392, Kruskal-Wallis ANOVA test; N = 10-12 per group). In every group, training and test session latencies were significantly different, indicating that they have learned the task (P < 0.05, Wilcoxon signed ranks test), as shown in Fig. 1 .
The performance of rats receiving post-training bilateral intrahippocampal infusion of 2, 10 or 20 lM of the TRPV1 antagonist capsazepine, is shown in Fig. 2. Step-down latencies were not different among the groups, neither in the training (P = 0.586) nor in the test sessions (P = 0.277, Kruskal-Wallis ANOVA test; N = 10-12 per group). In every group, training and test session latencies were significantly different (P < 0.05, Wilcoxon signed ranks test) i.e., all groups have learned the task. These results suggest that the TRPV1 receptors may not be required to modulate memory consolidation of this task.
In the following experiment, we performed the same protocol, but given a higher foot-shock in the training (0.7 mA). The performance of rats receiving post-training bilateral intra-hippocampal infusion of 2, 10 or 20 lM of the TRPV1 antagonist capsazepine, is shown in Fig. 3. Step-down latencies were not different among the groups, neither in the training (P = 0.450) nor in the test sessions (P = 0.860, Kruskal-Wallis ANOVA test; N = 8-10 per group).
In the 10 lM group, but not in the other groups, there was no difference between the training and test session latencies (P > 0.05, Wilcoxon signed ranks test). These results suggest that the TRPV1 receptors may be required to modulate memory consolidation of this task under a high foot-shock training (0.7 mA), but not in a lower one (0.5 mA).
Effect of TRPV1 agonist and antagonist in the contextual fear conditioning task
In the next experiment, we investigated whether using a more aversive task would recruit the vanilloid system in order to modulate memory consolidation, as suggested by Marsch et al., 2007 . Thus, we have chosen the contextual fear conditioning task, in which 0.7 mA foot-shock was applied. Fig. 4 shows the freezing behavior exhibited during the test session by animals that received a bilateral intra-hippocampal infusion of 0.1, 1 or 10 lM of capsaicin after the CFC training. There was no significant difference among the groups (F (3,38) = 0.460, P = 0.712, One-way ANOVA test; N = 9-13 per group).
Fig. 5 displays the freezing behavior performed during the test session by animals that received a bilateral intra-hippocampal infusion of 2, 10 or 20 lM of the TRPV1 antagonist capsazepine after CFC training. There was a significant difference among the groups (F (3,35) = 3.233, P = 0.034, One-way ANOVA test). Tukey post-hoc test revealed a significant effect of 10 lM of capsazepine that was able to impair memory compared with the control group (P < 0.05).
We then asked whether the endovanilloid system was required for memory consolidation in the case of a mild foot-shock (0.3 mA) protocol in the same task. Fig. 6 shows the freezing behavior performed during the test by animals that received bilateral intrahippocampal infusion of the previously effective dose of capsazepine Fig. 1 . Effect of intrahippocampal infusion of capsaicin in step-down inhibitory avoidance task (0.5 mA) upon memory consolidation. Kruskal-Wallis test shows no significant differences among training or test session latencies. Bars represent interquartile ranges of step-down latencies, with the median as a thick line; fine horizontal lines represent minimum and maximum values. (a) Significant differences between training and test session latencies (P < 0.05, Wilcoxon test, Ns = 11, 10, 12, 11). Fig. 2 . Effect of intrahippocampal infusion of capsazepine in the step-down inhibitory avoidance task (0.5 mA) upon memory consolidation. Kruskal-Wallis test shows no significant differences among training or test session latencies. Bars represent interquartile ranges of step-down latencies, with the median as a thick line; fine horizontal lines represent minimum and maximum values. (a) Significant differences between training and test session latencies (P < 0.05, Wilcoxon test, Ns = 12, 10, 11, 11). Fig. 3 . Effect of intrahippocampal infusion of capsazepine in the step-down inhibitory avoidance task (0.7 mA) upon memory consolidation. Kruskal-Wallis test shows no significant differences among training or test session latencies. Bars represent interquartile ranges of step-down latencies, with the median as a thick line; fine horizontal lines represent minimum and maximum values. (a) Significant differences between training and test session latencies (P < 0.05, Wilcoxon test, Ns = 8, 9, 9, 10). Fig. 4 . Effect of bilateral intrahippocampal infusion of capsaicin in the contextual fear conditioning task (0.7 mA) upon memory consolidation. There were no significant differences among the groups in the freezing time spent in the test session performed 24 h after conditioning (P > 0.05 One-way ANOVA, Ns = 9, 11, 13, 9). Data expressed as mean + SEM.
in the weak training protocol. One-way ANOVA shows that there was no difference among the groups (F (3,27) = 0.143, P = 0.933; N = 6-9 per group). Hence, these results suggest that the endovanilloid is recruited in order to modulate memory consolidation through the hippocampal TRPV1 activation only when a strong training is presented.
In order to exclude for any possible non-cognitive effect of the effective dose of capsazepine, we tested some animals on the elevated plus maze task. Student t test revealed that there was no difference of intra-hippocampal infusion of capsazepine neither in the time spent in the open arms (t (13) = 0.431, P = 0.674) nor in the number of entries in the open or closed arms (P > 0.05) compared with the control group, as given in Table 1 .
Discussion
The present study examined the role of the hippocampal endovanilloid system upon memory consolidation in contextual fear conditioning and step-down inhibitory avoidance. The main result found here is that TRPV1 antagonist capsazepine was able to impair memory consolidation only in the strong shock condition (Figs. 3 and 5 ). In contrast, such effect was absent under a weak conditioning protocol. These results suggest that endovanilloids are required to modulate hippocampal memory consolidation only when a strong emotional experience is present. Moreover, TRPV1 agonist capsaicin does not show any effect neither in fear conditioning nor in step-down inhibitory avoidance task (Figs. 1 and 4) .
We have chosen the dorsal region of the hippocampus because it is involved with cognitive functions, such as IA and CFC memory tasks (de Oliveira Alvares, Genro, Diehl, & Quillfeldt, 2008; de Oliveira Alvares et al., 2010) . The ventral region is known to be related to emotion and affect, not within our objectives. For a wider review upon the functional distinction between dorsal and ventral hippocampus, see Fanselow & Dong, 2010. Recent studies have described that endocannabinoid system is recruited in the hippocampus in order to modulate memory under a strong fear training protocol, but not under a weak one (de Oliveira Alvares et al., 2010) or less aversive tasks (de Oliveira Alvares et al., 2006; Hölter et al., 2005; Niyuhire et al., 2007) , suggesting that a certain level of aversiveness or emotional status is necessary to exert its effect on memory (de Oliveira Alvares et al., 2010) . Furthermore, there are results reporting that anandamide release is increased in response to stress (Hohmann et al., 2005) , glucocorticoids (Di, Malcher-Lopes, Halmos, & Tasker, 2003; Di, Malcher-Lopes, Marcheselli, Bazan, & Tasker, 2005) or emotional memories (Kamprath et al., 2006; Marsicano et al., 2002) . Some results from cannabinoids research might be partially transposed to vanilloid studies since anandamide is an endogenous ligand to both CB1 and TRPV1 receptors. In fact, our current data corroborate these cannabinoid reports, demonstrating an amnesic effect of capsazepine upon memory consolidation, suggesting a modulatory influence by endovanilloids such as anandamide upon TRPV1 receptors in a markedly stressful/aversive learning.
TRPV1 receptor-deficient mice have shown memory impairment of contextual fear conditioning and LTP induction in hippocampus slices when compared with the wild-type littermate (Marsch et al., 2007) . In accordance with the present results, the effect of TRPV1 ablation was evident only after a strong conditioning procedure (Marsch et al., 2007) . Li and colleagues have reported that TRPV1 agonist capsaicin has no effect per se in memory retrieval, but prevented the acute stress effect on spatial memory retrieval (Li et al., 2008) . . Typical acceptable needle placement, aimed at the CA1 region (according to Paxinos and Watson (2007) ) of the rat dorsal hippocampus (formol thionine technique). Taken together, these results suggest that during an emotional learning, where a significant stressful experience such as a strong foot-shock occur, endovanilloids may be acting upon TRPV1 receptors in order to modulate positively memory consolidation. Interestingly, at least in hippocampus, endovanilloids and endocannabinoids seems to play a complementary role in memory consolidation, since CB1 blockade in CA1 area impair memory consolidation (de Oliveira Alvares et al., 2005 , and low concentration of anandamide in dorsal hippocampus improves memory (de Oliveira Alvares et al., 2008) .
In addition, endocannabinoids/endovanilloids can enhance LTP induction either through CB1 (Carlson, Wang, & Alger, 2002) or TRPV1 (Li et al., 2008) activation in hippocampus. Despite the fact that CB1 and TRPV1 have opposite transductional mechanisms (inhibitory and excitatory, respectively), they are expressed at different synaptic sites -CB1 are located pre-synaptically both in gabaergic and glutamatergic neurons, but are much more concentrated in the GABA synapse (Kawamura et al., 2006) -whereas TRPV1 are found in the postsynaptic dendritic spines and cell somata (Cristino et al., 2006; Tóth et al., 2005) . This distribution may explain the similar electrophysiological and behavioral results both CB1 and TRPV1 activation seem to promote.
Therefore, based on the fact that (a) anandamide can act both as endogenous cannabinoid and vanilloid, that (b) anandamide enhances memory consolidation, and that (c) CB1 or TRPV1 antagonists cause memory impairment only in a markedly aversive learning situation, we suggest that the endocannabinoid and the endovanilloid systems play a complementary role, at least in memory consolidation processes taking place in the in dorsal hippocampus.
In the inhibitory avoidance, we found a moderate effect on memory consolidation using 0.7 mA foot-shock. The capsazepine 10 lM treated group did not learn the task (i.e., no difference between training and test latencies). However, no difference was found when compared with the control group. Although both tasks used in the present study involve aversive compounds, there are some differences between them. In the IA, animals can avoid the foot-shock, maintaining themselves on the platform. On the other hand, in fear conditioning task, animals expect to receive the aversive stimuli anytime. This difference becomes clear evaluating their behavior. In the first case, animals move and perform riskassessment, whereas in fear conditioning, they express fear response through freezing around 70% of the whole time. Therefore, it is reasonable to consider that contextual fear conditioning is more aversive than the inhibitory avoidance task. In addition, in the contextual fear conditioning, animals received more footshocks than inhibitory avoidance paradigm in the protocol used in this work. It also might explain the stronger effect found in the contextual fear conditioning compared with the partial effect shown in the IA task.
Due to their central and peripheric expression, TRPV1 receptors can interfere on non-mnemonic aspects, such as mobility (de Lago, de Miguel, Lastres-Becker, Ramos, & Fernández-Ruiz, 2004) , anxiety (Rubino et al., 2008) or pain perception (Cortright & Szallasi, 2009) . Since these effects could overshadow the acquisition and/ or expression of memory, we have performed an additional behavioral measurement in order to exclude the possibility of an anxiety effect. Capsazepine infused into the dorsal hippocampus did not cause any effect in the elevated plus maze compared to controls. Thus, the effects presented here seem to be purely mnemonic.
In summary, our experiments suggest that the endovanilloid system plays an important role upon memory consolidation acting through the activation of TRPV1 receptors in the dorsal hippocampus. However, it happens only when a certain level of aversiveness is present, which seems to be a boundary condition for its recruitment. The convergence of these results and others here cited suggest that a synergic interaction is taking place between the CB1 and the TRPV1 receptor in the dorsal hippocampus in order to modulate memory consolidation.
